|
2024
|
Invention
|
Antibodies targeting disease associated antigen and γδ t cell receptors and uses thereof. The pre... |
|
|
Invention
|
Variable heavy chain only libraries, methods of preparation thereof, and uses thereof.
The prese... |
|
2022
|
Invention
|
Anti-egfr antibodies, anti-cmet antibodies, anti-vegf antibodies, multispecific antibodies, and u... |
|
2021
|
Invention
|
Variable heavy chain only libraries, methods of preparation thereof, and uses thereof. The presen... |
|
|
Invention
|
A shielded and homing bispecific antibody that simultaneously inhibits angiogenic pathway targets... |
|
|
Invention
|
Shielded biologics with masking domains to shield antigen binding capability of biologics and use... |
|
2020
|
Invention
|
Agents that interfere with thymic stromal lymphopoietin (tslp)-receptor signaling. e.g.ccc gamma ... |
|
|
Invention
|
Agents that interfere with thymic stromal lymphopoietin (tslp)-receptor signaling. The present di... |
|
|
Invention
|
Agents that interfere with il-1beta receptor signalling. The present disclosure relates to antibo... |
|
|
Invention
|
Bispecific antibodies to tnf-alpha and il-1beta and uses thereof. The present disclosure relates ... |
|
|
Invention
|
Modulator of antigen specific t cell (modastc) molecules and uses thereof. The present disclosure... |
|
|
Invention
|
Bispecific antibodies to tnf-alpha and il-1beta and uses thereof.
The present disclosure relates... |
|
|
Invention
|
Tricyclic peptide as protein binders and modulators and uses thereof. The present disclosure rela... |
